Browse the corpus

Walk the Even Hospital Database by book and chapter — the raw source passages that ground Ask, DDx, and the rest.

3 passages

continuing_education_activitystatpearls· Continuing Education Activity· item NBK535451

Dopamine is a dose-dependent, peripheral vasopressor used to manage hypotension, bradycardia, and cardiac arrest. The effect of dopamine varies depending on the infusion rate. At moderate doses, dopamine increases cardiac output through β1-adrenergic stimulation, whereas higher doses result in vasoconstriction and elevated blood pressure via α1-adrenergic effects. Given its complex pharmacologic profile and risk of adverse effects and drug interactions, dopamine requires careful titration, precise dosing, close monitoring, and evidence-based use to optimize safety and efficacy. This activity reviews dopamine’s mechanism of action, clinical indications, dosing, adverse effects, and drug interactions. Emphasis is placed on evidence-based use, patient-specific considerations, and strategies to minimize complications and maximize therapeutic outcomes. This activity equips healthcare professionals with practical tools and skills to individualize care, ensure appropriate dopamine use across diverse clinical scenarios, and enhance clinical outcomes. Interprofessional collaboration enhances outcomes through comprehensive monitoring, accurate dose titration, and proactive management of potential complications. Objectives: Identify the pharmacological mechanisms and dose-dependent effects of dopamine at low, intermediate, and high infusion rates. Differentiate the clinical indications and physiological responses associated with various dopamine dosing ranges. Assess the potential adverse effects associated with dopamine therapy. Collaborate and communicate effectively within the interprofessional healthcare team to improve outcomes and treatment efficacy for patients receiving dopamine therapy. Access free multiple choice questions on this topic.

toxicitystatpearls· Toxicity· item NBK535451

Signs and Symptoms of Overdose or Toxicity According to Sax's Dangerous Properties of Industrial Materials (by Richard J. Lewis, 2004; DOI: 10.1002/0471701343), studies in rodents showed an LD50 (lethal dose in 50% of subjects) ranging from 59 to 163 mg/kg. In humans, dopamine can lead to peripheral vasoconstriction, resulting in gangrenous extremities and cardiac arrhythmias.[60][61][62] Additionally, it can cause severe hypertension, tachycardia, confusion, and agitation. Management of Overdose or Toxicity No specific antidote exists for a dopamine overdose. If overdose is suspected, the infusion should be discontinued immediately. Symptoms generally resolve rapidly due to dopamine’s short half-life. If symptoms persist, an alpha-adrenergic blocker such as phentolamine may be administered. Phentolamine can also be used to treat tissue necrosis resulting from dopamine extravasation.[63] Dopamine extravasation leads to intense local alpha-1–mediated vasoconstriction, ischemia, and potential necrosis. Phentolamine, a nonselective alpha-adrenergic antagonist, blocks these receptors, reversing vasoconstriction and restoring perfusion. Phentolamine is administered subcutaneously around the site of extravasation to prevent or treat ischemic injury. Topical nitroglycerin and subcutaneous terbutaline can be used as alternatives if phentolamine is unavailable or contraindicated.[64]

enhancing_healthcare_team_outcomesstatpearls· Enhancing Healthcare Team Outcomes· item NBK535451

Dopamine administration has widespread effects on the cardiovascular system, kidneys, and CNS. Safe and effective use requires awareness of contraindications, including drug interactions with other pharmaceutical agents, lifestyle factors, and conditions that place similar strain on these organ systems. Medications such as psychopharmacological agents, neuroleptics, and general anesthetics, along with physiological stressors such as exercise-induced cardiac demand, may alter dopamine's impact and patient safety. An evidence-based approach, aligned with clear outcome objectives, is essential for optimal care. An interprofessional approach is critical to the safe and effective use of dopamine. Clinicians determine the indication for therapy, initiate treatment, and titrate dosing based on the patient’s hemodynamic status. Emergency medicine clinicians are often involved in the early recognition and management of complications, including accidental overdose or extravasation injuries. Clinical pharmacists enhance patient safety by reviewing prescriptions for accuracy, monitoring for potential drug interactions, and providing guidance to the healthcare team on best practices, such as the use of phentolamine for extravasation management. Nurses provide continuous bedside monitoring, focusing on vital signs, infusion rates, and patient concerns, and serve as key communicators of changes in patient status. Effective interprofessional communication and coordination among primary care providers, emergency clinicians, pharmacists, nurses, and therapists are critical to patient-centered care. By sharing information, anticipating complications, and reinforcing one another's responsibilities, the healthcare team can enhance patient outcomes, minimize risks, and support safe and ethical use of dopamine therapy.